Michael Rabson, SVP Business Dev/Legal & GC at Cytokinetics, holds 20.04K shares in Cytokinetics (Ticker: CYTK). Most recently, Michael Rabson Bought $15,000 shares of Cytokinetics on Dec 21, 2009 for an estimated value of 27.75K.
What is the percentage of profitable transactions made by Michael Rabson?
The percentage of profitable transactions made by Michael Rabson is ―.
What is the average return per transaction made by Michael Rabson?
The average return per transaction made by Michael Rabson is ―.
What stocks does Michael Rabson hold?
Michael Rabson holds: CYTK stocks.
What was Michael Rabson’s latest transaction?
Michael Rabson latest transaction was an Informative Buy of $27.75K.
What was Michael Rabson's most profitable transaction?
Michael Rabson’s most profitable transaction was an Informative Buy of CYTK stock on December 21, 2009. The return on the trade was -17.70%.
What is Michael Rabson's role in Cytokinetics?
Michael Rabson's role in Cytokinetics is SVP Business Dev/Legal & GC.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.